HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease.

AbstractCONTEXT:
Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent in Egypt, in parallel with increasing obesity. NAFLD can lead to liver inflammation, fibrosis and cirrhosis. NAFLD appears tightly linked with metabolic syndrome (MetS).
OBJECTIVE:
Examine the impact of dietary fish oil on human patients with MetS and NAFLD.
MATERIALS AND METHODS:
One hundred and forty patients were enrolled in the current study and classified into two groups: patients with both MetS and NAFLD and patients with MetS alone. Sixty-four patients were treated with daily supplementation of 2 g of fish oil for 6 months. Markers of hyperlipidemia and oxidative stress, hydrogen peroxide (H(2)O(2)) and malondialdhyde (MDA), as well as proinflammatory cytokines, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), were analyzed.
RESULTS:
Patients without fish oil exhibited significant increases in triglycerides (TGs), low-density lipoprotein (LDL), H(2)O(2) and MDA that were associated with significantly elevated TNF-α and IL-6 compared to controls. Furthermore, patients with both NAFLD and MetS showed significant increase in H(2)O(2), MDA, TNF-α and IL-6 levels compared with MetS group (p < 0.05). Treatment with fish oil reduced serum level of TG, LDL-cholesterol (LDL-C), H(2)O(2), MDA, TNF-α and IL-6 levels in patients and did not affect the control levels.
DISCUSSION AND CONCLUSION:
Patients with NAFLD had bad lipid profile through a mechanism that involved developed redox imbalance, characterized by boosted free-radical activity and lipid peroxidation enhancing the release of proinflammatory cytokines leading to increased MetS risk and liver damage. However, daily treatment of patients with fish oil for 6 months improved lipid profile and blocked the oxidative stress and cytokines release.
AuthorsMohammed M H Al-Gayyar, Mohamed E E Shams, Enaase A M E Barakat
JournalPharmaceutical biology (Pharm Biol) Vol. 50 Issue 3 Pg. 297-303 (Mar 2012) ISSN: 1744-5116 [Electronic] England
PMID22103753 (Publication Type: Journal Article)
Chemical References
  • Cytokines
  • Fish Oils
  • Lipids
Topics
  • Adult
  • Aged
  • Case-Control Studies
  • Cytokines (metabolism)
  • Egypt
  • Fatty Liver (complications, drug therapy, physiopathology)
  • Female
  • Fish Oils (pharmacology)
  • Humans
  • Inflammation (drug therapy, physiopathology)
  • Lipid Metabolism (drug effects)
  • Lipid Peroxidation (drug effects)
  • Lipids (blood)
  • Male
  • Metabolic Syndrome (complications, drug therapy, physiopathology)
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease
  • Oxidative Stress (drug effects)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: